Since higher cost of operations is a major deterrent at the moment, Indian pharma companies see the likely implications in ...

Nvidia and Wistron's touted progress toward reshoring American manufacturing during a grand opening event Tuesday.

Industrials have quietly stopped being a reshoring story and started being an AI infrastructure bet, and the distinction changes everything about where the rally goes from here.

Manufacturing has multiple futures: automated, AI-enabled and more resilient. The winners will be those that build the people ...

Track pharma stocks as Trump's phased US tariff plan hits sentiment, though analysts say India's cost edge may cushion ...

Trump's tariff roadmap for generic drug imports is aimed at encouraging pharmaceutical manufacturing in the US, with Indian ...

US President proposes zero tariff on imported generic medicines for two years before duties rise to 100% and later 200% to ...

Trump's proposed generic drug tariff could reshape India's pharmaceutical strategy, US supply chains, and the global ...

MISUMI Americas, a specification-driven sourcing partner for mechanical components and assemblies, today announced The Rise of U.S. Manufacturing report. U.S. manufacturing added hit a record $2.91 ...

The future of manufacturing will not be won by big ideas alone. From AI and automation to modernization and reshoring, the ...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but ...